XOMA

XOMA Corporation

Price

return (12m)

p/e

25.99

p/bv

6.20

DIVIDEND YIELD

0.00%

XOMA price

XOMA

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment XOMA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals XOMA

Valuation

P/E

25.99

Sector -4.38

Industry -4.38

P/BV

6.20

Sector 2.02

Industry 2.02

P/Revenue (PSR)

19.31

Sector -4.40

Industry -4.40

EV/EBITDA

Sector -263.09

Industry -263.09

EV/EBIT

Sector -702.90

Industry -702.90

P/EBITDA

17.93

Sector -4.39

Industry -4.39

P/EBIT

19.60

Sector -4.73

Industry -4.73

P/Total Assets

2.57

Sector 1.49

Industry 1.49

P/Net Current Assets

Sector -11.70

Industry -11.70

P/Working Capital

Sector -3.19

Industry -3.19

EPS

1.55

Sector -2.14

Industry -2.14

BVPS

6.48

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

93.30%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-7.27%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

13.73%

Sector -38.22%

Industry -38.22%

Net Profit Margins

74.29%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.05

Sector 0.03

Industry 0.03

Profitability

ROE

23.84%

Sector -65.14%

Industry -65.14%

ROA

9.90%

Sector -65.53%

Industry -65.53%

ROIC

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -6.07

Industry -6.07

Net Debt / EBIT

Sector -8.26

Industry -8.26

Net Debt / Equity

Sector -1.07

Industry -1.07

Gross Debt / Equity

Sector -0.05

Industry -0.05

Equity/Assets

0.42

Sector 0.41

Industry 0.41

Liabilities/Assets

0.58

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-1.03%

Sector -

Industry -

5Y Earnings CAGR

28.15%

Sector -

Industry -

FAIR VALUE OF XOMA ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$15.03

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals XOMA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XOMA XOMA Corporation	$0.00	-100.00%	0.00%	25.99	6.20	23.84%	74.29%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XOMA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT XOMA

XOMA Corporation

Average Investor10 user rating

4.0 (0 people)

United States

45 years

Founded: 1981

1986

Time since IPO - 40 years

10

Employees

XOMA Corporation (United States) is listed on the Nasdaq and has a market capitalization of $699.64 million, with shareholders equity totaling $112.90 million.

The company employs approximately 10 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, XOMA Corporation reported $36.23 million in revenue, generating net income of $26.92 million.

Key financial metrics include a P/E ratio of 25.99, a price-to-book (P/B) ratio of 6.20, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XOMA.

Market cap

$699.64 million

Net worth

$112.90 million

$112,895,000.00

Assets

$271.86 million

$271,858,000.00

Total Shares Outstanding

17.42 million

17,417,000

Average Daily Trading Volume

$259.94 Thousand

$259,939.00

Sector

Health Care

Industry

Biotechnology

XOMA

XOMA revenue and profits

Financial Results XOMA

DRAG THE FRAME TO SEE MORE DATA

XOMA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of XOMA (XOMA) today?

A cotação de XOMA (XOMA) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de XOMA (XOMA) iniciou o ano negociando na casa dos US$ 26.59 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de XOMA (XOMA) e dados de ações do Ibovespa e mercados internacionais.

Quando XOMA (XOMA) paga dividendos?

XOMA (XOMA) não distribuiu dividendos no último ano.

Is XOMA (XOMA) a good investment?

Atualmente, XOMA (XOMA) está cotada a US$ 0.00, com um P/L de 25.99, representando um desvio de -2,118% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy XOMA (XOMA) stock?

Investir em ações de XOMA (XOMA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of XOMA (XOMA) yield today?

A rentabilidade de XOMA (XOMA) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de XOMA (XOMA) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

XOMA

XOMA Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment XOMA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING XOMA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT XOMA

XOMA Corporation

United States

45 years

1986

10

PROFIT X PRICE XOMA

Financial Results XOMA

XOMA cash flow

Asset, Revenue and Profit Growth - XOMA

XOMA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions